US20110184350A1 - Needle guide system - Google Patents
Needle guide system Download PDFInfo
- Publication number
- US20110184350A1 US20110184350A1 US12/693,853 US69385310A US2011184350A1 US 20110184350 A1 US20110184350 A1 US 20110184350A1 US 69385310 A US69385310 A US 69385310A US 2011184350 A1 US2011184350 A1 US 2011184350A1
- Authority
- US
- United States
- Prior art keywords
- needle
- lock
- guide
- needle guide
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000007 visual effect Effects 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims description 28
- 239000011800 void material Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000023178 Musculoskeletal disease Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000020307 Spinal disease Diseases 0.000 description 2
- -1 arthroplasty to maintain motion Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000037873 arthrodesis Diseases 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000018180 degenerative disc disease Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001721 transfer moulding Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3401—Puncturing needles for the peridural or subarachnoid space or the plexus, e.g. for anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/347—Locking means, e.g. for locking instrument in cannula
Definitions
- the present disclosure generally relates to a guide for needle insertion, and more particularly to a needle guide system effective to retain an inserted needle at a proper depth inside a patient.
- Needles may be used to transfer an agent, drug or other substance into a patient.
- the needle may be inserted into the patient at a desired location.
- the needle may be hollow and include a hollow tip.
- a syringe with a drug may be attached to an end of the needle so that the drug may flow from the syringe, through the hollow needle, through the needle tip and into the patient.
- An epidural injection may be used to help reduce the pain caused by a herniated disc, degenerative disc disease, or spinal stenosis. These spinal disorders often affect the cervical (neck) and lumbar (lower back) areas of the spine.
- the medicine used in the injection is usually a combination of a local anesthetic (e.g. bupivacaine) and a steroid (e.g. triamcinolone).
- a local anesthetic e.g. bupivacaine
- a steroid e.g. triamcinolone
- the technique and risks of the procedure are similar to those for standard epidural analgesia.
- the technique is believed to work by reducing the inflammation or swelling, or both, of the nerves in the epidural space.
- Needle placement for epidurals around the spine and nerve roots are typically performed under fluoroscopic guidance.
- a needle may be inserted near the spine and a practitioner may consult a fluoroscope display to ensure that the needle placement is at the proper location and depth.
- the fluoroscope provides a display so as to avoid inadvertently inserting the needle within adjacent nerve structures.
- An example application of needle placement is the injection of epidural steroid drugs near compressed and inflamed nerve roots to treat sciatica, back pain or leg pain.
- the doctor first inserts a needle into a patient at a desired location.
- a syringe with a drug may be connected to the needle.
- the doctor may exchange the syringe with another syringe to inject different compounds into the patient during the procedure.
- the present disclosure describes an improvement over these prior art technologies.
- a guide for needle insertion is provided, and more particularly to a needle guide system effective to retain an inserted needle at a proper depth inside a patient.
- a needle guide system comprising a needle guide including at least one wall defining an internal cavity of the needle guide; a lock connected to the needle guide, the lock movable between a first and a second position; and a needle disposed in the internal cavity of the needle guide, the needle having a long axis and a tip.
- the needle is movable along the long axis with respect to the needle guide when the lock is in the first position.
- the needle is locked to the needle guide and the tip extends beyond the wall of the needle guide when the lock is in the second position.
- Another embodiment of the disclosure is a method for inserting a needle into a patient.
- the method comprises inserting a needle into an internal cavity of a needle guide, the needle guide including at least one wall defining the internal cavity, the needle having a long axis and a tip, the inserting the needle including moving the needle along the long axis.
- the method further comprises inserting the needle into a patient; moving a lock connected to the needle guide from a first position to a second position to lock the needle to the guide when the tip extends beyond the wall of the needle guide; and connecting a syringe to the needle.
- Yet another embodiment of the disclosure is a needle guide comprising at least one wall defining an internal cavity of the needle guide; and a lock, the lock movable between a first and a second position.
- the needle guide is effective to receive a needle in the internal cavity, the needle having a long axis and a tip.
- the lock is effective to allow the needle to move along the long axis with respect to the needle guide when the lock is in the first position.
- the lock is effective to lock the needle to the needle guide where the tip extends beyond the wall of the needle guide when the lock is in the second position.
- the lock including visual indicia indicating whether the lock is in the first or the second position.
- FIG. 1 is a side view of one particular embodiment of a needle, guide and syringe in accordance with the principles of the present disclosure
- FIG. 2 is a top cut-away view of the guide shown in FIG. 1 ;
- FIG. 3 is a top cut-away view of the guide shown in FIG. 1 ;
- FIG. 4 is a top cut-away view of the guide shown in FIG. 1 ;
- FIGS. 5A and 5B are top cut-away views of the guide shown in FIG. 1 ;
- FIGS. 6A and 6B are top cut-away views of the guide shown in FIG. 1 .
- the exemplary embodiments of the needle guide system and methods of use disclosed are discussed in terms of medical treatment devices and more particularly, in terms of a needle guide system and method for treating the spine.
- the guide system and methods of use disclosed provide improved guidance for a needle inserted in a patient. It is further envisioned that the present disclosure may be employed to treat musculoskeletal disorders including sacro-Iliac dysfunction or syndrome, dehydration, destabilization, laxity, fracture, tumor, spinal disorders and other orthopedic disorders. It is contemplated that the present disclosure may be employed with surgical treatments, including open surgery, percutaneous procedures involving use of a needle or cannula, percutaneous and minimally invasive procedures of such disorders, such as, for example, arthroplasty to maintain motion, arthrodesis including fusion, bone graft and implantable prosthetics.
- the present disclosure may be employed with other osteal and bone related applications, including those associated with diagnostics and therapeutics.
- the disclosed needle guide system and methods may be employed in a surgical treatment with a patient in a prone or supine position, employing a posterior, lateral, inferior, posterior-inferior, superior or anterior approach.
- the present disclosure may be employed with procedures for treating the lumbar, cervical, thoracic and pelvic regions of a spinal column.
- Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
- FIGS. 1-6B there are illustrated components of the needle guide system in accordance with the principles of the present disclosure.
- the components of the needle guide system are fabricated from materials suitable for medical applications, including metals, synthetic polymers, ceramics, bone, biocompatible materials and/or their composites, depending on the particular application and/or preference of a medical practitioner.
- the components of the needle guide system such as the guide, lock and/or needle, discussed below, may be monolithically formed, integrally connected or configured as an insert.
- Different components of the needle guide system may have alternative material composites to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference.
- the components of the needle guide system may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials.
- a needle guide system 50 in accordance with the disclosure includes a needle 64 , a syringe 52 and a guide 54 .
- Needle 64 includes a needle end 66 , a needle body 60 and a needle tip 62 .
- Needle 64 has a long axis 74 .
- Syringe 52 includes an opening 68 , a body 70 and a tip 72 .
- Syringe 52 may be detachably connected to needle 64 such as by friction fit, screw and thread, tongue and groove, protuberance and/or hole arrangements.
- Syringe 52 is shown as having a shape that is a combination of a cut-off hollow cylinder and a funnel. Other shapes and arrangements could also be used for syringe 52 such as, for example, ellipsoids, rectangular solids, pyramids, cylinders, frustums, or any other shape.
- body 70 of guide 54 includes at least one wall, such as, for example, a wall 55 defining a substantially hollow cylinder with an internal cavity 57 .
- Tip 72 is shown as being hemispherical shape including an arcuate portion 76 .
- Arcuate portion 76 allows needle 64 and guide 54 to be placed oblique to skin surface 58 .
- Arcuate portion 76 is curved or rounded to allow needle 64 to be angled at a desired position to locate tip 62 to penetrate the intended target, for example, under fluoroscopic guidance.
- body 70 and tip 72 could also be used.
- ellipsoids, rectangular solids, pyramids, cylinders, frustums, or any shape could be used for either or both body 70 and tip 72 .
- the surface of tip 72 can be smooth and continuous, planar, textured, dimpled, rough, staggered, offset and/or coated with therapeutic agents and/or pharmacological agents.
- opening 68 and body 70 of guide 54 may be larger than a diameter of needle 64 so that needle 64 can move longitudinally along axis 74 relative to guide 54 . It is contemplated that opening 68 may be variously sized and configured according to a particular needle application. It is further contemplated that tip 72 and/or portions thereof adjacent opening 68 may be rigid, semi-rigid and/or flexible to facilitate targeting and guidance of needle 64 to a random or pre-selected location.
- Needle guide 54 is employed to prevent movement of needle 64 relative to needle guide 54 and relative to a patient. Undesired movement of needle 64 in the patient can lead to needle migration and inadvertent penetration, which can lead to patient complications and associated health risks.
- the needle guide system includes a lock 56 that is connected to needle guide 54 . Lock 56 may be disposed on any portion of guide 54 .
- Lock 56 defines an elongated shaft 75 , which is configured for lateral, slidable movement through side openings 77 of wall 55 . Openings 77 are configured for slidable movement of shaft 75 therein. It is contemplated that the cross-sectional geometry of shaft 75 may have various configurations, for example, round, oval, oblong, triangular, rectangular, polygonal, irregular, uniform, non-uniform, consistent or variable. It is further contemplated that the diameter or thickness of shaft 75 may be offset, tapered, converging and/or diverging. Lock 56 may have a linear locking pin configuration and/or include angled portions for locking engagement with wall 55 .
- Shaft 75 has a circumferential outer surface 81 , which includes a continuous first diameter portion 84 .
- Portion 84 extends continuously, having a smooth, even configuration, to an arcuate portion 82 , which has a reduced diameter relative to first diameter portion 84 .
- Arcuate portion 82 gradually decreases in diameter and tapers to a minimum dimension, and continues to extend to gradually increase in diameter to an opposing portion of first diameter portion 84 .
- the surface of arcuate portion 82 is configured to receive needle 64 for slidable relative engagement.
- the surface of portion 84 is configured to engage needle 64 in a friction or interference engagement to fix the position of needle 64 relative to needle guide 54 .
- Arcuate portion 82 defines a diameter that is smaller than the diameter defined by portion 84 . It is contemplated that outer surface 81 , the surface of portion 84 and/or the surface of portion 82 may individually or collectively be smooth, textured, planar and/or rough.
- Needle 64 is inserted into needle guide 54 and can move relative to guide 54 along axis 74 ( FIG. 1 ) when lock 56 is in a first position so that needle 64 is disposed in arcuate portion 82 .
- Arcuate portion 82 allows movement of needle 64 .
- Needle 64 tends to remain toward a center of guide 54 because tip 72 includes walls maintaining needle 64 in a center of guide 54 as shown in FIG. 4 .
- lock 56 is moved to a second position so that needle 64 engages the outer surface of portion 84 , friction between the surfaces of portion 84 and needle 64 inhibit movement of needle 64 along axis 74 .
- a user may thus lock needle 64 with respect to needle guide 54 by engaging lock 56 into the second, locked position. For example, as shown in FIG. 3 , lock 56 may be moved from right to left to engage portion 84 with needle 64 .
- Lock 56 includes visual indicia to indicate that needle 64 is a first position, free to slidably move relative to guide 54 and/or needle 64 is a second position such that needle 64 is locked and fixed relative to guide 54 .
- Lock 56 is color coded to provide such visual indicia.
- a first side 86 of lock 56 includes a first color, such as, for example, the color green.
- a second side 88 of lock 56 includes a second color, such as, for example the color red.
- first side 86 including green color extends outside of opening 77 and beyond wall 55 of guide 54 .
- second side 88 of lock 56 includes a second color, such as, for example the color red.
- the green color indicates that needle 64 is movable relative to guide 54 because needle 64 is disposed in engagement with arcuate portion 82 .
- visual indicia including the color red will be provided to the practitioner.
- the red color indicates that needle 64 is locked and because needle 64 disposed in a frictional or interference engagement with portion 84 and is fixed relative to guide 54 .
- various colors may be employed.
- alternate visual indicia may be used such as shapes and/or graduated markings.
- tactile or audible indicia may also be employed.
- lock 56 may include an adjustable internal void. Walls 90 , 92 defining the void may be moved to engage or release needle 64 .
- the void may be defined by a hollow cylinder, straight walls and/or curved walls.
- FIGS. 5A and 5B show examples where lock 56 includes an adjustable void defined by curved walls 90 .
- FIGS. 6A and 6B show examples where lock 56 includes an adjustable void defined by straight walls 92 .
- needle guide system 50 includes a rotation mechanism, such as, for example, a knurled wheel connected or attached to guide 54 .
- the knurled wheel is rotated, via manipulation or mechanical control, to cause an internal mechanism, such as, for example, a lever or shaft, such as, lock 56 described herein, to lock needle 64 in a desired position/orientation.
- needle guide system 50 similar to that described above includes a lever extending from guide 54 . The lever is movable to cause an internal mechanism, described above, to lock needle in a desired position/orientation.
- needle 64 may be placed at an inside of body 70 of guide 54 prior to insertion of needle 64 attached to a catheter into a patient.
- a practitioner identifies a suitable anatomical gap between the bony spinous processes prior to the procedure.
- a target location for needle penetration is determined.
- the level of the spine at which needle 64 is placed depends on the needle site and type of an intended operation or the anatomical origin of pain.
- the practitioner conducting an epidural places the catheter in the mid-lumbar, or lower back region of the spine.
- the patient's skin may be infiltrated with local anaesthetic such as lidocaine over the identified space.
- the insertion point is usually in the midline, although other approaches, such as the paramedian approach, may occasionally be employed.
- distal tip 72 includes curved portion 76 , such that the combination of guide 54 and needle 64 may be angled at a desired position relative to an intended target.
- the combination may be moved with respect to skin surface 58 so that axis 74 of needle 64 may be inserted oblique to skin surface 58 .
- Lock 56 is in the first position such that the portion of first side 86 including green color extends outside of opening 77 and beyond wall 55 of guide 54 , thereby providing visual indicia including the color green to the practitioner.
- the green color indicates that needle 64 is movable relative to guide 54 because needle 64 is disposed in engagement with arcuate portion 82 .
- Needle 64 is inserted through skin surface 58 under fluoroscopic guidance.
- lock 56 may be engaged to lock needle 64 in a fixed position relative to guide 54 to prevent undesired movement of needle 64 relative to needle guide 54 and relative to a patient, such as needle migration and inadvertent penetration, which can lead to patient complications and associated health risks.
- Lock 56 is pushed or engaged so that portion 84 frictionally engages needle 64 .
- the portion of second side 88 including red color extends outside opening 77 and beyond wall 55 of guide 54 , thereby providing visual indicia including the color red to the practitioner.
- the red color indicates that needle 64 is locked because needle 64 disposed in a frictional or interference engagement with portion 84 and is fixed relative to guide 54 .
- This movement also moves first side 86 , with green color, inside of guide 54 and moves second side 88 , with a red color, outside of guide 54 .
- Such locking prevents needle 64 from inadvertently being pushed deeper into a patient.
- Needle tip 62 extends beyond wall 55 .
- Syringe 52 including a pharmacological and/or therapeutic agent 41 may be selectively connected to and/or disconnected from needle 64 .
- lock 56 may be disengaged. Lock 56 is engaged at the portion of second side 88 including red color so that second side 88 is pushed inside of guide 54 and first side 86 extends outside of guide 54 . Needle 64 is freely slidable relative to guide 54 . An alternate syringe may be connected to needle 64 , and/or needle 64 and guide 54 can be removed from a patient. Needle 64 may thereafter be removed from guide 54 by disengaging lock 56 .
- guide 54 is fabricated, includes an outer layer and/or is coated with a radiolucent material such as a polymer, in a configuration such that guide 54 is not detected during fluoroscopic imaging.
- the components of needle guide system 50 such as, for example, guide 54 includes one or a plurality of sensors mounted therewith that are detectable so that guide 54 can be detected and/or the trajectory of needle 64 can be tracked using three-dimensional stereotactic equipment for accurate placement of needle tip 62 .
- the sensors may include LCD sensors and/or other detectable biocompatible sensors.
- the components of the needle guide system can be manufactured via various methods.
- the components of the needle guide system can be manufactured and assembled via injection-molding, insert-molding, overmolding, compression molding, transfer molding, co-extrusion, pultrusion, dip-coating, spray-coating, powder-coating, porous-coating, milling from a solid stock material, and their combinations.
- injection-molding insert-molding, overmolding, compression molding, transfer molding, co-extrusion, pultrusion, dip-coating, spray-coating, powder-coating, porous-coating, milling from a solid stock material, and their combinations.
Abstract
Description
- The present disclosure generally relates to a guide for needle insertion, and more particularly to a needle guide system effective to retain an inserted needle at a proper depth inside a patient.
- Needles may be used to transfer an agent, drug or other substance into a patient. The needle may be inserted into the patient at a desired location. The needle may be hollow and include a hollow tip. A syringe with a drug may be attached to an end of the needle so that the drug may flow from the syringe, through the hollow needle, through the needle tip and into the patient.
- An epidural injection, or epidural steroid injection, may be used to help reduce the pain caused by a herniated disc, degenerative disc disease, or spinal stenosis. These spinal disorders often affect the cervical (neck) and lumbar (lower back) areas of the spine.
- The medicine used in the injection is usually a combination of a local anesthetic (e.g. bupivacaine) and a steroid (e.g. triamcinolone). The technique and risks of the procedure are similar to those for standard epidural analgesia. The technique is believed to work by reducing the inflammation or swelling, or both, of the nerves in the epidural space.
- Needle placement for epidurals around the spine and nerve roots are typically performed under fluoroscopic guidance. A needle may be inserted near the spine and a practitioner may consult a fluoroscope display to ensure that the needle placement is at the proper location and depth. The fluoroscope provides a display so as to avoid inadvertently inserting the needle within adjacent nerve structures.
- An example application of needle placement is the injection of epidural steroid drugs near compressed and inflamed nerve roots to treat sciatica, back pain or leg pain. In such a procedure, the doctor first inserts a needle into a patient at a desired location. A syringe with a drug may be connected to the needle. Thereafter, the doctor may exchange the syringe with another syringe to inject different compounds into the patient during the procedure. The present disclosure describes an improvement over these prior art technologies.
- Accordingly, a guide for needle insertion is provided, and more particularly to a needle guide system effective to retain an inserted needle at a proper depth inside a patient.
- One embodiment of the disclosure a needle guide system comprising a needle guide including at least one wall defining an internal cavity of the needle guide; a lock connected to the needle guide, the lock movable between a first and a second position; and a needle disposed in the internal cavity of the needle guide, the needle having a long axis and a tip. The needle is movable along the long axis with respect to the needle guide when the lock is in the first position. The needle is locked to the needle guide and the tip extends beyond the wall of the needle guide when the lock is in the second position.
- Another embodiment of the disclosure is a method for inserting a needle into a patient. The method comprises inserting a needle into an internal cavity of a needle guide, the needle guide including at least one wall defining the internal cavity, the needle having a long axis and a tip, the inserting the needle including moving the needle along the long axis. The method further comprises inserting the needle into a patient; moving a lock connected to the needle guide from a first position to a second position to lock the needle to the guide when the tip extends beyond the wall of the needle guide; and connecting a syringe to the needle.
- Yet another embodiment of the disclosure is a needle guide comprising at least one wall defining an internal cavity of the needle guide; and a lock, the lock movable between a first and a second position. The needle guide is effective to receive a needle in the internal cavity, the needle having a long axis and a tip. The lock is effective to allow the needle to move along the long axis with respect to the needle guide when the lock is in the first position. The lock is effective to lock the needle to the needle guide where the tip extends beyond the wall of the needle guide when the lock is in the second position. The lock including visual indicia indicating whether the lock is in the first or the second position.
- The present disclosure will become more readily apparent from the specific description accompanied by the following drawings, in which:
-
FIG. 1 is a side view of one particular embodiment of a needle, guide and syringe in accordance with the principles of the present disclosure; -
FIG. 2 is a top cut-away view of the guide shown inFIG. 1 ; -
FIG. 3 is a top cut-away view of the guide shown inFIG. 1 ; -
FIG. 4 is a top cut-away view of the guide shown inFIG. 1 ; -
FIGS. 5A and 5B are top cut-away views of the guide shown inFIG. 1 ; and -
FIGS. 6A and 6B are top cut-away views of the guide shown inFIG. 1 . - Like reference numerals indicate similar parts throughout the figures.
- The exemplary embodiments of the needle guide system and methods of use disclosed are discussed in terms of medical treatment devices and more particularly, in terms of a needle guide system and method for treating the spine.
- It is envisioned that the guide system and methods of use disclosed provide improved guidance for a needle inserted in a patient. It is further envisioned that the present disclosure may be employed to treat musculoskeletal disorders including sacro-Iliac dysfunction or syndrome, dehydration, destabilization, laxity, fracture, tumor, spinal disorders and other orthopedic disorders. It is contemplated that the present disclosure may be employed with surgical treatments, including open surgery, percutaneous procedures involving use of a needle or cannula, percutaneous and minimally invasive procedures of such disorders, such as, for example, arthroplasty to maintain motion, arthrodesis including fusion, bone graft and implantable prosthetics. It is further contemplated that the present disclosure may be employed with other osteal and bone related applications, including those associated with diagnostics and therapeutics. The disclosed needle guide system and methods may be employed in a surgical treatment with a patient in a prone or supine position, employing a posterior, lateral, inferior, posterior-inferior, superior or anterior approach. The present disclosure may be employed with procedures for treating the lumbar, cervical, thoracic and pelvic regions of a spinal column.
- The present invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
- The following discussion includes a description of a needle guide system, related components and exemplary methods of employing the needle guide system in accordance with the principles of the present disclosure. Alternate embodiments are also disclosed. Reference will now be made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures. Turning now to
FIGS. 1-6B , there are illustrated components of the needle guide system in accordance with the principles of the present disclosure. - The components of the needle guide system are fabricated from materials suitable for medical applications, including metals, synthetic polymers, ceramics, bone, biocompatible materials and/or their composites, depending on the particular application and/or preference of a medical practitioner. The components of the needle guide system, such as the guide, lock and/or needle, discussed below, may be monolithically formed, integrally connected or configured as an insert. Different components of the needle guide system may have alternative material composites to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference. The components of the needle guide system may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials.
- It has been discovered that in prior art systems as a practitioner disconnects and connects syringes, the force applied to an inserted needle can lead to the needle migrating further into the patient. Such migration may occur without the practitioner's knowledge, possibly leading to complications if the needle tip enters a nerve or vascular structure.
- Referring to
FIG. 1 , aneedle guide system 50 in accordance with the disclosure includes aneedle 64, asyringe 52 and aguide 54.Needle 64 includes aneedle end 66, aneedle body 60 and aneedle tip 62.Needle 64 has along axis 74. -
Guide 54 includes anopening 68, abody 70 and atip 72.Syringe 52 may be detachably connected toneedle 64 such as by friction fit, screw and thread, tongue and groove, protuberance and/or hole arrangements.Syringe 52 is shown as having a shape that is a combination of a cut-off hollow cylinder and a funnel. Other shapes and arrangements could also be used forsyringe 52 such as, for example, ellipsoids, rectangular solids, pyramids, cylinders, frustums, or any other shape. - In the embodiment shown,
body 70 ofguide 54 includes at least one wall, such as, for example, awall 55 defining a substantially hollow cylinder with aninternal cavity 57.Tip 72 is shown as being hemispherical shape including anarcuate portion 76.Arcuate portion 76 allowsneedle 64 and guide 54 to be placed oblique toskin surface 58. -
Arcuate portion 76 is curved or rounded to allowneedle 64 to be angled at a desired position to locatetip 62 to penetrate the intended target, for example, under fluoroscopic guidance. However, other shapes and arrangements forbody 70 andtip 72 could also be used. For example, ellipsoids, rectangular solids, pyramids, cylinders, frustums, or any shape could be used for either or bothbody 70 andtip 72. It is contemplated that the surface oftip 72 can be smooth and continuous, planar, textured, dimpled, rough, staggered, offset and/or coated with therapeutic agents and/or pharmacological agents. - Referring also to
FIG. 2 , opening 68 andbody 70 ofguide 54 may be larger than a diameter ofneedle 64 so thatneedle 64 can move longitudinally alongaxis 74 relative to guide 54. It is contemplated that opening 68 may be variously sized and configured according to a particular needle application. It is further contemplated thattip 72 and/or portions thereofadjacent opening 68 may be rigid, semi-rigid and/or flexible to facilitate targeting and guidance ofneedle 64 to a random or pre-selected location. -
Needle guide 54 is employed to prevent movement ofneedle 64 relative toneedle guide 54 and relative to a patient. Undesired movement ofneedle 64 in the patient can lead to needle migration and inadvertent penetration, which can lead to patient complications and associated health risks. The needle guide system includes alock 56 that is connected toneedle guide 54.Lock 56 may be disposed on any portion ofguide 54. -
Lock 56 defines anelongated shaft 75, which is configured for lateral, slidable movement throughside openings 77 ofwall 55.Openings 77 are configured for slidable movement ofshaft 75 therein. It is contemplated that the cross-sectional geometry ofshaft 75 may have various configurations, for example, round, oval, oblong, triangular, rectangular, polygonal, irregular, uniform, non-uniform, consistent or variable. It is further contemplated that the diameter or thickness ofshaft 75 may be offset, tapered, converging and/or diverging.Lock 56 may have a linear locking pin configuration and/or include angled portions for locking engagement withwall 55. -
Shaft 75 has a circumferentialouter surface 81, which includes a continuousfirst diameter portion 84.Portion 84 extends continuously, having a smooth, even configuration, to anarcuate portion 82, which has a reduced diameter relative tofirst diameter portion 84.Arcuate portion 82 gradually decreases in diameter and tapers to a minimum dimension, and continues to extend to gradually increase in diameter to an opposing portion offirst diameter portion 84. The surface ofarcuate portion 82 is configured to receiveneedle 64 for slidable relative engagement. The surface ofportion 84 is configured to engageneedle 64 in a friction or interference engagement to fix the position ofneedle 64 relative toneedle guide 54. -
Arcuate portion 82 defines a diameter that is smaller than the diameter defined byportion 84. It is contemplated thatouter surface 81, the surface ofportion 84 and/or the surface ofportion 82 may individually or collectively be smooth, textured, planar and/or rough. -
Needle 64 is inserted intoneedle guide 54 and can move relative to guide 54 along axis 74 (FIG. 1 ) whenlock 56 is in a first position so thatneedle 64 is disposed inarcuate portion 82.Arcuate portion 82 allows movement ofneedle 64.Needle 64 tends to remain toward a center ofguide 54 becausetip 72 includeswalls maintaining needle 64 in a center ofguide 54 as shown inFIG. 4 . Whenlock 56 is moved to a second position so thatneedle 64 engages the outer surface ofportion 84, friction between the surfaces ofportion 84 andneedle 64 inhibit movement ofneedle 64 alongaxis 74. A user may thus lockneedle 64 with respect to needle guide 54 by engaginglock 56 into the second, locked position. For example, as shown inFIG. 3 , lock 56 may be moved from right to left to engageportion 84 withneedle 64. -
Lock 56 includes visual indicia to indicate thatneedle 64 is a first position, free to slidably move relative to guide 54 and/orneedle 64 is a second position such thatneedle 64 is locked and fixed relative to guide 54.Lock 56 is color coded to provide such visual indicia. - A
first side 86 oflock 56 includes a first color, such as, for example, the color green. Asecond side 88 oflock 56 includes a second color, such as, for example the color red. In this way, when the portion offirst side 86 including green color extends outside of opening 77 and beyondwall 55 ofguide 54, visual indicia including the color green will be provided to the practitioner. The green color indicates thatneedle 64 is movable relative to guide 54 becauseneedle 64 is disposed in engagement witharcuate portion 82. - When the portion of
second side 88 including red color extendsoutside opening 77 and beyondwall 55 ofguide 54, visual indicia including the color red will be provided to the practitioner. The red color indicates thatneedle 64 is locked and becauseneedle 64 disposed in a frictional or interference engagement withportion 84 and is fixed relative to guide 54. It is envisioned that various colors may be employed. It is further envisioned that alternate visual indicia may be used such as shapes and/or graduated markings. It is contemplated that tactile or audible indicia may also be employed. - Other structures may be used for
lock 56. For example,arcuate portion 82 may be removed fromlock 56. In this way,needle 64 is free to move relative to guide 54 except whenportion 84 is engaged withneedle 64. In other examples, as shown inFIGS. 5A , 5B, 6A and 6B, lock 56 may include an adjustable internal void.Walls needle 64. For example, the void may be defined by a hollow cylinder, straight walls and/or curved walls.FIGS. 5A and 5B show examples wherelock 56 includes an adjustable void defined bycurved walls 90.FIGS. 6A and 6B show examples wherelock 56 includes an adjustable void defined bystraight walls 92. In one embodiment,needle guide system 50, similar to that described above, includes a rotation mechanism, such as, for example, a knurled wheel connected or attached to guide 54. The knurled wheel is rotated, via manipulation or mechanical control, to cause an internal mechanism, such as, for example, a lever or shaft, such as, lock 56 described herein, to lockneedle 64 in a desired position/orientation. In one embodiment,needle guide system 50, similar to that described above includes a lever extending fromguide 54. The lever is movable to cause an internal mechanism, described above, to lock needle in a desired position/orientation. - Referring again to
FIG. 1 , in use during administration of an epidural application,needle 64 may be placed at an inside ofbody 70 ofguide 54 prior to insertion ofneedle 64 attached to a catheter into a patient. A practitioner identifies a suitable anatomical gap between the bony spinous processes prior to the procedure. A target location for needle penetration is determined. The level of the spine at which needle 64 is placed depends on the needle site and type of an intended operation or the anatomical origin of pain. - The practitioner conducting an epidural places the catheter in the mid-lumbar, or lower back region of the spine. The patient's skin may be infiltrated with local anaesthetic such as lidocaine over the identified space. The insertion point is usually in the midline, although other approaches, such as the paramedian approach, may occasionally be employed.
- As
distal tip 72 includescurved portion 76, such that the combination ofguide 54 andneedle 64 may be angled at a desired position relative to an intended target. For example, the combination may be moved with respect toskin surface 58 so thataxis 74 ofneedle 64 may be inserted oblique toskin surface 58.Lock 56 is in the first position such that the portion offirst side 86 including green color extends outside of opening 77 and beyondwall 55 ofguide 54, thereby providing visual indicia including the color green to the practitioner. - The green color indicates that
needle 64 is movable relative to guide 54 becauseneedle 64 is disposed in engagement witharcuate portion 82.Needle 64 is inserted throughskin surface 58 under fluoroscopic guidance. Whenneedle 64 is at its desired location, lock 56 may be engaged to lockneedle 64 in a fixed position relative to guide 54 to prevent undesired movement ofneedle 64 relative toneedle guide 54 and relative to a patient, such as needle migration and inadvertent penetration, which can lead to patient complications and associated health risks. -
Lock 56 is pushed or engaged so thatportion 84 frictionally engagesneedle 64. The portion ofsecond side 88 including red color extendsoutside opening 77 and beyondwall 55 ofguide 54, thereby providing visual indicia including the color red to the practitioner. The red color indicates thatneedle 64 is locked becauseneedle 64 disposed in a frictional or interference engagement withportion 84 and is fixed relative to guide 54. - This movement also moves
first side 86, with green color, inside ofguide 54 and movessecond side 88, with a red color, outside ofguide 54. Such locking preventsneedle 64 from inadvertently being pushed deeper into a patient.Needle tip 62 extends beyondwall 55.Syringe 52 including a pharmacological and/ortherapeutic agent 41 may be selectively connected to and/or disconnected fromneedle 64. - If a practitioner desires to reposition
needle 64,lock 56 may be disengaged.Lock 56 is engaged at the portion ofsecond side 88 including red color so thatsecond side 88 is pushed inside ofguide 54 andfirst side 86 extends outside ofguide 54.Needle 64 is freely slidable relative to guide 54. An alternate syringe may be connected toneedle 64, and/orneedle 64 and guide 54 can be removed from a patient.Needle 64 may thereafter be removed fromguide 54 by disengaginglock 56. In one embodiment, guide 54 is fabricated, includes an outer layer and/or is coated with a radiolucent material such as a polymer, in a configuration such that guide 54 is not detected during fluoroscopic imaging. In one embodiment, the components ofneedle guide system 50 such as, for example, guide 54 includes one or a plurality of sensors mounted therewith that are detectable so thatguide 54 can be detected and/or the trajectory ofneedle 64 can be tracked using three-dimensional stereotactic equipment for accurate placement ofneedle tip 62. The sensors may include LCD sensors and/or other detectable biocompatible sensors. - It is envisioned that the components of the needle guide system can be manufactured via various methods. For example, the components of the needle guide system can be manufactured and assembled via injection-molding, insert-molding, overmolding, compression molding, transfer molding, co-extrusion, pultrusion, dip-coating, spray-coating, powder-coating, porous-coating, milling from a solid stock material, and their combinations. One skilled in the art, however, will realize that such materials and fabrication methods suitable for assembly and manufacture, in accordance with the present disclosure, would be appropriate.
- It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplification of the various embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
Claims (20)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/693,853 US8267895B2 (en) | 2010-01-26 | 2010-01-26 | Needle guide system |
PCT/US2011/022588 WO2011094322A2 (en) | 2010-01-26 | 2011-01-26 | Needle guide system |
JP2012551266A JP2013517901A (en) | 2010-01-26 | 2011-01-26 | Needle guide system |
EP11737585.7A EP2528644A4 (en) | 2010-01-26 | 2011-01-26 | Needle guide system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/693,853 US8267895B2 (en) | 2010-01-26 | 2010-01-26 | Needle guide system |
Publications (2)
Publication Number | Publication Date |
---|---|
US20110184350A1 true US20110184350A1 (en) | 2011-07-28 |
US8267895B2 US8267895B2 (en) | 2012-09-18 |
Family
ID=44309496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/693,853 Active 2031-01-16 US8267895B2 (en) | 2010-01-26 | 2010-01-26 | Needle guide system |
Country Status (4)
Country | Link |
---|---|
US (1) | US8267895B2 (en) |
EP (1) | EP2528644A4 (en) |
JP (1) | JP2013517901A (en) |
WO (1) | WO2011094322A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140052079A1 (en) * | 2011-04-28 | 2014-02-20 | Sanofi-Aventis Deutschland Gmbh | Valve arrangement for medical device |
US20150065993A1 (en) * | 2013-09-03 | 2015-03-05 | Max Arocha | Double-chamber mixing syringe and method of use |
US20170035653A1 (en) * | 2009-10-29 | 2017-02-09 | Cook Incorporated | Coaxial needle cannula with distal spiral mixer and side ports for fluid injection |
CN110236648A (en) * | 2019-06-25 | 2019-09-17 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | A kind of bone surgery sting device having defencive function and its application method |
US10470712B2 (en) * | 2014-06-19 | 2019-11-12 | Sipple Medical, Llc | Biomarker detection and identification system and apparatus |
US11452575B2 (en) * | 2017-08-28 | 2022-09-27 | Boston Scientific Scimed, Inc. | Devices and methods to access a target within the body |
US11583362B2 (en) * | 2017-08-28 | 2023-02-21 | Boston Scientific Scimed, Inc. | Devices and methods to access a target within the body |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10080877B2 (en) | 2014-07-25 | 2018-09-25 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a drug cartridge |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
US10549081B2 (en) | 2016-06-23 | 2020-02-04 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312351A (en) * | 1993-01-29 | 1994-05-17 | Gerrone Carmen J | Combined pneumo-needle and trocar apparatus |
US6391005B1 (en) * | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US20070179474A1 (en) * | 2005-12-29 | 2007-08-02 | Cahill Ryan J | Syringe activated-valve for flushing a catheter and methods thereof |
US20080077093A1 (en) * | 2006-09-06 | 2008-03-27 | Christian Gratwohl | Needle protecting device comprising a lock |
US20080208138A1 (en) * | 2007-02-26 | 2008-08-28 | Becton, Dickinson & Company | Syringe having a hinged needle shield |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3487837A (en) | 1967-02-06 | 1970-01-06 | Roy A Petersen | Device for holding catheters in position |
US3765420A (en) | 1971-12-16 | 1973-10-16 | Kendall & Co | Eccentric locking device for surgical drainage members |
US3783876A (en) * | 1972-05-04 | 1974-01-08 | Kendall & Co | Tabbed eccentric locking device |
FR2586568A1 (en) | 1985-09-02 | 1987-03-06 | Putscher Claude | Protective device intended for people using needles for medicinal injections |
DE19611868A1 (en) * | 1996-03-26 | 1997-10-02 | Basf Ag | Arylamine as a marking agent for wood |
DE19808220B4 (en) * | 1997-06-19 | 2007-11-29 | Mri Devices Daum Gmbh | Nadeltrokar |
US6235001B1 (en) | 1998-05-18 | 2001-05-22 | O'holloran Brian | Surgical needle with hand-actuable lock mechanism |
US6689142B1 (en) | 1999-04-26 | 2004-02-10 | Scimed Life Systems, Inc. | Apparatus and methods for guiding a needle |
US6833709B2 (en) * | 2002-07-26 | 2004-12-21 | Motorola, Inc. | Low loss fuel cell configuration |
US20070129744A1 (en) | 2005-12-01 | 2007-06-07 | Klaus Teichert | Acupuncture needle guide assembly |
US7442199B2 (en) | 2005-12-27 | 2008-10-28 | Hong Dar Teng | Clip for acupuncture needle |
DE102006041128A1 (en) * | 2006-09-01 | 2008-03-20 | Tecpharma Licensing Ag | Safety pin module with a detent mechanism and a usage label |
-
2010
- 2010-01-26 US US12/693,853 patent/US8267895B2/en active Active
-
2011
- 2011-01-26 EP EP11737585.7A patent/EP2528644A4/en not_active Withdrawn
- 2011-01-26 WO PCT/US2011/022588 patent/WO2011094322A2/en active Application Filing
- 2011-01-26 JP JP2012551266A patent/JP2013517901A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312351A (en) * | 1993-01-29 | 1994-05-17 | Gerrone Carmen J | Combined pneumo-needle and trocar apparatus |
US6391005B1 (en) * | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US20070179474A1 (en) * | 2005-12-29 | 2007-08-02 | Cahill Ryan J | Syringe activated-valve for flushing a catheter and methods thereof |
US20080077093A1 (en) * | 2006-09-06 | 2008-03-27 | Christian Gratwohl | Needle protecting device comprising a lock |
US20080208138A1 (en) * | 2007-02-26 | 2008-08-28 | Becton, Dickinson & Company | Syringe having a hinged needle shield |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170035653A1 (en) * | 2009-10-29 | 2017-02-09 | Cook Incorporated | Coaxial needle cannula with distal spiral mixer and side ports for fluid injection |
US10596067B2 (en) * | 2009-10-29 | 2020-03-24 | Cook Medical Technologies Llc | Coaxial needle cannula with distal spiral mixer and side ports for fluid injection |
US20140052079A1 (en) * | 2011-04-28 | 2014-02-20 | Sanofi-Aventis Deutschland Gmbh | Valve arrangement for medical device |
US9814872B2 (en) * | 2011-04-28 | 2017-11-14 | Sanofi-Aventis Deutschland Gmbh | Valve arrangement for medical device |
US20150065993A1 (en) * | 2013-09-03 | 2015-03-05 | Max Arocha | Double-chamber mixing syringe and method of use |
US10420888B2 (en) * | 2013-09-03 | 2019-09-24 | Max Arocha | Double-chamber mixing syringe and method of use |
US10470712B2 (en) * | 2014-06-19 | 2019-11-12 | Sipple Medical, Llc | Biomarker detection and identification system and apparatus |
US11452575B2 (en) * | 2017-08-28 | 2022-09-27 | Boston Scientific Scimed, Inc. | Devices and methods to access a target within the body |
US11583362B2 (en) * | 2017-08-28 | 2023-02-21 | Boston Scientific Scimed, Inc. | Devices and methods to access a target within the body |
CN110236648A (en) * | 2019-06-25 | 2019-09-17 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | A kind of bone surgery sting device having defencive function and its application method |
Also Published As
Publication number | Publication date |
---|---|
EP2528644A4 (en) | 2014-03-19 |
US8267895B2 (en) | 2012-09-18 |
WO2011094322A3 (en) | 2011-12-08 |
JP2013517901A (en) | 2013-05-20 |
WO2011094322A2 (en) | 2011-08-04 |
EP2528644A2 (en) | 2012-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8267895B2 (en) | Needle guide system | |
KR100188292B1 (en) | Method and apparatus for variably regulating the length of a combined spinal-epidural needle | |
CA2151006C (en) | Method and apparatus for adjusting the length of a combined spinal-epidural needle | |
Karmakar et al. | Thoracic paravertebral block for management of pain associated with multiple fractured ribs in patients with concomitant lumbar spinal trauma | |
US20140228670A1 (en) | Surgical implant guide system and method | |
US11957388B2 (en) | Deformable body and combination of such deformable body and a surgical screw element | |
JP2018535004A (en) | Tissue retractor system and method | |
US11478587B2 (en) | Drug depot delivery system and method | |
US20140066990A1 (en) | Multi-planar axial spinal rod connector | |
US20150201974A1 (en) | Surgical instrument and method of use | |
CN112535800B (en) | Enhanced probe for long-acting preparation syringe | |
US11672961B2 (en) | Drug pellet injector needle and method technical field | |
Protić et al. | Benefit of the minimal invasive ultrasound-guided single shot femoro-popliteal block for ankle surgery in comparison with spinal anesthesia. | |
US9936988B2 (en) | Surgical system and method | |
EP3212269B1 (en) | Device for controlled delivery of medical devices | |
US20140257418A1 (en) | Surgical tool holder | |
Tognù et al. | In-plane ultrasound-guided lumbar plexus block using catheter-over-needle technique in a 14-month-old baby | |
Azimi et al. | Low profile halo head fixation in non-human primates | |
US20010049518A1 (en) | Method of delivering a beneficial agent employing a steerable catheter | |
RU2694512C1 (en) | Method of catheterisation of epidural space in children with idiopathic scoliosis of thoracic localization with value more than 90° | |
US20140066989A1 (en) | Adjustable axial spinal rod connector | |
US20230083239A1 (en) | Needle Having Multiple Dispensing Units | |
CA2998697A1 (en) | Control mechanism for steerable rod | |
US11439353B2 (en) | Multi-cannula sensing device | |
Protić et al. | Vorteil des minimal invasiven Ultraschall-gezielten femoro-poplitealen" single-shot" Blocks im Vergleich zur Spinalanästhesie bei Knöcheloperationen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WARSAW ORTHOPEDIC, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCKAY, WILLIAM F.;REEL/FRAME:023855/0770 Effective date: 20100125 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |